Patent · US Active

2-aza-bicyclo[3.3.0]octane derivatives

US8288429B2 · kind B2 · utility

13Cited by

1References

13Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Hamed Aissaoui · Allschwil, CH
Christoph Boss · Allschwil, CH
Markus Gude · Allschwil, CH
Ralf Koberstein · Bad Kötzting, DE
Thierry Sifferlen · Allschwil, CH
Daniel TRACHSEL · Bern, CH

Key dates

Filing date	Jul 25, 2008
Grant date	Oct 16, 2012
Priority date	—
Expiry date	Sep 7, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 2-aza-bicyclo[3.3.0]octane derivatives of Formula (I) wherein A, B, and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.